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SUMMARY
Objective: The purposes of this study were to evaluate the potential for testicular sperm extraction (TESE)
from azoospermic patients with non-mosaic Klinefelter’s syndrome and to determine the outcome of
intracytoplasmic sperm injection (ICSI) using the extracted testicular sperm sample.
Materials and Methods: Fourteen couples suffering from primary infertility in which the male partner had the
azoospermic non-mosaic 47,XXY karyotype (Klinefelter’s syndrome) participated in this study. All of the women
underwent controlled ovarian hyperstimulation. Open testis biopsies were conducted 1 day prior to or on the
day of oocyte retrieval. Motile sperm, extracted from the biopsied tissues in a wet preparation, were used for
ICSI. The outcome of ICSI was evaluated from the fertilization rate, embryo-cleavage rate, clinical pregnancy
rate, and chromosomal status of resultant fetuses or delivered babies.
Results: Sperm retrieval was successful in eight of 14 patients (sperm retrieval rate, 57%). In total, 118 mature
oocytes were injected with extracted motile spermatozoa. This resulted in the production of 70 fertilized oocytes
(fertilization rate, 59%) and 67 embryos (cleavage rate, 96%). Among the eight women who underwent embryo
transfer, six achieved clinical pregnancies (clinical pregnancy rate, 75%). The outcome of these pregnancies
included one blighted ovum and the birth of four male and five female healthy babies. The live delivery rate
was 62.5%. All of these babies were chromosomally and physiologically normal.
Conclusion: This study demonstrates that azoospermic patients suffering from non-mosaic Klinefelter’s
syndrome can father their own genetic offspring when the TESE procedure is combined with ICSI and embryo
transfer techniques. [Taiwanese J Obstet Gynecol 2004;43(2):88–96]
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■  ORIGINAL ARTICLE  ■
Introduction
Klinefelter’s syndrome, initially described in 1942, is
characterized by hypogonadism, small testes, azoosper-
mia, and gynecomastia [1]. Patients with Klinefelter’s
syndrome have an additional X chromosome [2].
About 90% of affected patients have the non-mosaic
form of this syndrome, with a chromosomal consti-
tution of 47,XXY, and this form is believed to arise due
to meiotic non-disjunction of the chromosomes during
gametogenesis [3]. The remaining 10% of patients have
the mosaic form, the usual chromosomal constitu-
tion of which is 46,XY/47,XXY; this form is thought
to result from chromosomal mitotic non-disjunction
arising after fertilization of the zygote [3].
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Klinefelter’s syndrome is the most frequent sex
chromosomal abnormality, occurring in 0.1% of the
general phenotypic male population [4]. The incidence
can be 3.1% in the infertile male population [5] and 11%
in the azoospermic male population [6,7]. Klinefelter’s
syndrome in the mosaic form sometimes presents with
severe oligospermia, although these patients are able to
father their own genetic offspring by a combination of
oocyte retrieval, intracytoplasmic sperm injection (ICSI),
and embryo-transfer techniques [8]. By contrast, men
suffering from non-mosaic Klinefelter’s syndrome are
typically azoospermic and are considered by many to be
sterile. The observation that altered X chromosome
dosage elicits germ-cell loss during testicular develop-
ment has been made for virtually all male mammals,
including humans [9], such that virtually no sperm cells
are present in adult XXY testes [10–12]. However, rare
break-through patches of spermatogenesis-active tissue
have been reported in the testes of non-mosaic 47,XXY
males [13–15], and occasional motile spermatozoa have
been observed in the ejaculate of patients exhibiting
the non-mosaic 47,XXY karyotype [10,11,15].
As pregnancy has been achieved using testicular
sperm extraction (TESE) combined with ICSI in patients
with abnormal seminiferous tubular function [16], sev-
eral successful attempts at achieving pregnancy have
been made in azoospermic patients suffering from non-
mosaic Klinefelter’s syndrome using this TESE-ICSI
technique. This procedure offers such patients the op-
portunity to bear their own genetic offspring. According
to our review of the literature, about 23 deliveries
have been reported following ICSI using testicu-
lar spermatozoa extracted from the testes of azoosper-
mic patients suffering from non-mosaic Klinefelter’s
syndrome [17–24].
The purpose of this study was to evaluate the feasi-
bility and outcome of ICSI using testicular spermato-
zoa extracted from azoospermic individuals suffering
from non-mosaic Klinefelter’s syndrome.
Materials and Methods
Patient characteristics
During the period from May 1998 to December 2001,
14 consecutive azoospermic patients, aged 21 to 39
years, were diagnosed as suffering from non-mosaic
Klinefelter’s syndrome following cytogenetic evaluation
of peripheral blood lymphocytes. These individuals all
sought infertility treatment at our infertility clinic and
were enrolled into this study.
All patients underwent a complete history and
physical examination. Serum hormones were analyzed
at the initial interview in 12 of these patients, and in-
cluded luteinizing hormone (LH), follicle-stimulating
hormone (FSH), testosterone, and prolactin. The serum
inhibin B level was checked in four patients. Prior to un-
dergoing testicular biopsy for TESE, all patients needed
to undergo at least three separate medical examinations
to evaluate ejaculate using extensive sperm preparation
(ESP) to search for the occasional motile spermatozoa
that would be suitable for use in subsequent ICSI [25].
Such activity would have enabled us to avoid a testicular
biopsy in some patients.
Prior to undergoing TESE-ICSI, all patients were
advised regarding the potential genetic risks to their
future offspring resulting from the use of their own
sperm. All patients gave informed consent for partici-
pation in the study.
Testis biopsy, testicular sperm retrieval, and
sperm preparation
A testicular biopsy was conducted on either the day
prior to or the day of oocyte retrieval. Open testicular bi-
opsy for TESE was performed as described by Tournaye
et al [15]. Briefly, all patients received spinal anesthesia
and, subsequent to a hemiscrototomy, the scrotal
contents were inspected and small multifocal biopsies,
rather than a single large biopsy, were taken. If an intra-
operative search of the fresh tissues in the wet pre-
paration identified motile spermatozoa, testicular
sampling was halted. If no motile spermatozoa were
observed, more biopsies were taken until the entire
testicular mass had been randomly sampled. Careful
hemostasis was performed by means of unipolar
cauterization, and both testicular and scrotal incisions
were closed using interrupted resorbable sutures.
Biopsied testicular samples intended for sperm
extraction were transferred to a Petri dish (Falcon 3002;
Becton Dickinson Labware, Franklin Lakes, NJ, USA)
with pre-warmed HEPES-human tubal fluid (HTF; Ir-
vine Scientific, Santa Ana, CA, USA) and 3% synthetic
serum substitute (SSS; Irvine Scientific). The method
of sperm extraction from testicular tissue was modified
from that reported by Schlegel et al [26]. One small
sample of tissue per testis was sent for histology. Ini-
tially, testicular samples were dispersed and stretched
to isolate individual seminiferous tubules using
sterile glass slides. Subsequently, mechanical dispersal
of the tubules was accomplished by mincing of the ex-
tended tubules in pre-warmed HEPES-HTF/3% SSS
using a sterile pair of scissors.
Intraoperatively, a wet preparation of the suspension
was observed under an inverted microscope at 200×
and 400× magnification to identify motile spermatozoa.
The testicular tissue was then processed for sperm retrie-
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val according to the following technique. The dispersed
and minced testicular tissue was gently mixed with pre-
warmed HEPES-HTF/3% SSS and centrifuged at 500g
for 5 minutes after incubation at 37°C under 5% CO2
in air for 1 hour. The supernatant was further centri-
fuged at 1,800g for 5 minutes and the pellets were exa-
mined for the presence of motile spermatozoa. If mo-
tile spermatozoa were observed, the pellet was resus-
pended in 100 µL of HEPES-HTF/3% SSS and incu-
bated at 37°C in 5% CO2 in air for subsequent ICSI. If
more than 1.0 × 106 erythrocytes/mL were observed in
the sample, it was treated with erythrocyte-lysing buf-
fer (Sigma Chemical Co, St Louis, MO, USA) to increase
the chance of visualizing any motile spermatozoa that
may have been present [26]. In some cases, extensive
searching, sometimes for several hours, was needed to
find motile spermatozoa. If we failed to detect motile
spermatozoa following mechanical mincing and ery-
throcyte lysis, all residual tissue pieces from the shred-
ded biopsies were collected and further dissociated
by the addition of 800 IU/mL collagenase (Sigma C-
5138) and 10 µg/mL DNase (Sigma DN-25) in an at-
tempt to maximize the chance of sperm retrieval [27].
Protocol for ovarian stimulation, oocyte retrieval,
and ICSI
Stimulating the growth of multiple oocytes in female
partners was conducted using either an ultra-short or
a long intranasal spray ovarian-stimulation protocol.
For the ultra-short protocol, female partners received a
daily subcutaneous injection of 0.5 mg buserelin ace-
tate (Supremon; Hoechst AG, Frankfurt, Germany) from
days 2 to 4 of their menstrual cycle. Both human
menopausal gonadotropin (HMG; Serono, Auboune,
Switzerland) and human urinary FSH (Serono) or
recombinant FSH (Gonado-F, Serono, or Puregon,
Organon, Oss, Netherlands) were administered from
day 3. The initial dose of human gonadotropin depended
on the basal serum LH and FSH levels and the total
antral follicle count in both ovaries as revealed by a pre-
cycle examination on day 3. After day 9, the gonado-
tropin dose was adjusted according to both the serum
absolute estradiol (E2) level and the patterns of follicu-
lar growth and rise in serum E2 level. When the three
leading follicles reached 18 mm in diameter and the
serum E2 level was about 100–200 pg/mL per follicle
larger than 12 mm in diameter, a bolus of 10,000 IU
of human chorionic gonadotropin (HCG; Serono)
was injected intramuscularly to encourage final matu-
ration of the oocytes.
For the long protocol, buserelin acetate intranasal
spray (Supremon) was administered at 800 µg/day,
divided into four separate doses, in the luteal phase of
the participant’s menstrual cycle preceding the IVF cycle.
On day 2 of the participant’s menstrual cycle, the serum
E2 level was determined to ensure that pituitary de-
sensitization had been successfully achieved. When
the serum E2 level was less than 30 pg/mL, the dose of
buserelin acetate was dropped to 400 µg/day and both
HMG and urinary FSH or recombinant FSH were ad-
ministered to stimulate multiple oocyte growth. The
criteria for administering the initial dose of HMG and
FSH, those for the adjustment of the dose subsequent to
day 9, and those appropriate for the time of HCG injec-
tion were similar to those for the ultra-short protocol.
Ultrasound-guided transvaginal oocyte retrieval
was performed under light general anesthesia at about
34 to 36 hours after administration of HCG. ICSI was
performed according to the method of Van Steirteghem
et al [28].
Embryo transfer, luteal support, embryo
cryopreservation, and fetal karyotyping
At about 16 to 20 hours following the injection of oo-
cytes with sperm, fertilization was assessed by looking
for the presence of pronuclei within the injected oocytes.
Fertilization was considered normal when two pronuclei
were present. Appropriate grading criteria for embryo
quality were applied, and the process was conducted
according to the standard described by Scott et al [29].
Under normal circumstances, no more than three of
the best-quality embryos were transferred into the uterus
of the participating woman via the uterine cervix on day
3 following oocyte retrieval, under full-bladder status
and abdominal ultrasound guidance using a Labotec
(Labotec GmbH, Labor–Technik, Gottingen, Germany)
or an Edwards-Wallace (SIMS Portex, Hythe, Kent, UK)
embryo-transfer catheter. On a few occasions, we
transferred more than three embryos, but never more
than six, if we had specifically been requested to do so
by a participating couple who felt that the quality of a
frozen embryo was inferior to that of a “fresh” embryo,
and that the transfer of an embryo via a frozen cycle
might result in a decrease in the pregnancy rate. All
couples who requested transfer of more than three
embryos were informed of the possibility of the preg-
nancy resulting in a relatively high order of multiple
births. All such prospective parents consented to fetal
reduction if multiple pregnancies (≥ 3) were achieved.
If present, surplus embryos were frozen using a slow-
cooling method [30].
For luteal support, natural micronized progesterone
(Utrogestan; Piette International Laboratories, Brussels,
Belgium) 200 mg/day was administered in three doses
into the vagina from the day of oocyte retrieval and for
the following 16 days, at which time the serum β-HCG
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level was determined to assess pregnancy status. All
pregnant women received additional micronized pro-
gesterone (600 mg/day) until a gestational period of
10 weeks was reached. Clinical pregnancy was defined
as the sonographic demonstration of a gestational sac
with a visible fetal heart beat. Amniocentesis for fetal
karyotyping was recommended for all women who
achieved clinical pregnancy of 16 weeks’ gestation. For
couples who achieved pregnancy but were not willing to
undergo amniocentesis, cytogenetic evaluation of their
fetuses was not conducted until delivery had occurred.
Results
Physical features and serum hormone characteristics of
azoospermic patients with non-mosaic Klinefelter’s
syndrome observed in our study are presented in the
Table. The mean age of male patients was 33 ± 4 years
(range, 28–39 years) and of female partners was 29 ±
5 years (range, 21–39 years). The mean serum baseline
FSH level in male patients (39.33 ± 19.99 mIU/mL;
range, 13.2–83.6 mIU/mL) was somewhat elevated
compared to that in the normal population (2.0–
10.0 mIU/mL), while mean serum baseline testoster-
one level (1.72 ± 0.85 ng/mL; range, 0.46–3.18 ng/mL)
appeared to be below or near normal levels (2.7–
10.7 ng/mL). The levels of patient serum inhibin B
varied from less than 15 pg/mL to 164.25 pg/mL.
Around half of our patients exhibited mild gynecomastia
and all patients had small testicles (volume, 2–4 mL).
Six individuals had previously undergone testis
biopsy for simultaneous histologic examination and
investigation for the presence of spermatozoa at other
infertility centers prior to coming to our infertility clinic
for treatment. At that time, two of these six individuals
had undergone orchiopexy to treat an undescended
testis in connection with the testicular biopsy. No
spermatozoa had been recovered from any of these
patients during the procedure. We found sperm in the
ejaculate of two of the 14 patients by ESP. Sperm from
one of these patients was completely non-viable and
could not be used for ICSI. Sperm from the other patient
could be used, avoiding the need for testicular biopsy,
so this patient was not enrolled in the study.
Motile spermatozoa were found in the wet prepara-
tion of biopsied testicular tissue from eight patients,
giving a retrieval rate of 57%. Two individuals who had
spermatozoa retrieved in this attempt had previously
undergone testicular biopsy at another medical cen-
ter, one of whom had undergone orchiopexy in con-
nection with the testicular biopsy at that time. Motile
spermatozoa were retrieved by TESE from the patient
whose ejaculate had revealed dead spermatozoa follow-
ing the ESP. For all patients, histologic assessment of the
biopsied testicular tissue revealed tubal hyalinization,
no evidence of spermatogenesis, the absence of germ
cells, and relative hyperplasia of observed Leydig cells.
Table. Physical and serum hormone characteristics of 14 azoospermic patients with non-mosaic Klinefelter’s syndrome
Patient no. 1 2 3 4 5 6 7 8 9 10 11 12 13 14     Mean ± SD
Female age (yr) 31 29 39 30 21 27 28 26 27 25 35 29 26 34 29 ± 4.58
Male age (yr) 37 30 38 36 29 34 35 31 29 28 39 32 30 39 33 ± 3.97
Body height (cm) 176 169 ND 173 170 180 176 169 ND 172 ND 175 175 170 173 ± 3.54
Body weight (kg) 86 64 ND 62 76 92 106 55 ND 91 ND 54 78 78 77 ± 16.59
LH (mIU/mL) 32.7 19.75 ND 18.6 18 12.32 28.6 28.5 18.9 21.6 16.1 34.1 46.84 ND 24.67 ± 9.77
FSH (mIU/mL) 15.6 46 ND 40.1 65.9 29.72 32.7 30.2 49.7 13.2 36.05 29.2 83.6 ND 39.33 ± 19.99
Prolactin (ng/mL) 10.4 13.54 ND 20.6 19.8 9.85 7.31 11.4 11.4 13.2 7.29 19.7 13.32 ND 13.15 ± 4.63
Testosterone (ng/mL) 2.24 3.18 ND 0.91 0.51 2.95 1.32 1.58 2.01 1.58 2.08 1.78 0.46 ND 1.72 ± 0.85
Inhibin B (pg/mL) 66.1 164 64.2 < 15.0
Gynecomastia + – – – + + – – + + – + – +
Previous testis biopsy* + + – – – – – – – + + + – +
Orchiopexy – – – – – – – – – + – + – –
Sperm found by ESP + – – – – – – – – – – – – –
Sperm found by TESE + – + + + + – + + + – – – –
Clinical pregnancy quads – single twins – – – quads single triplets – – – –
Fetal reduction + – – – – – – + – + – – – –
Outcome 2 girls – Blighted 1 boy, – – – 1 boy, 1 boy 1 boy, – – – –
ovum  1 girl 1 girl 1 girl
*These patients had previously undergone testicular biopsy for TESE at another medical center. SD = standard deviation; ND = no data available;
LH = luteinizing hormone; FSH = follicle-stimulating hormone; ESP = extensive sperm preparation; TESE = testicular sperm extraction.
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In total, 118 mature oocytes were injected with re-
trieved spermatozoa using ICSI, resulting in two distinct
pronuclei in 70 oocytes, for a fertilization rate of 59%.
Of the 67 fertilized oocytes that developed into cleaved
embryos (cleavage rate, 96%), 62 were transferred,
which resulted in the development of 15 gestational
sacs featuring a visible heart beat (implantation rate,
24%). Of the eight women who underwent embryo
transfer, six had clinical pregnancies (clinical pregnancy
rate, 75%), including two singletons, one set of twins,
one set of triplets, and two sets of quadruplets. Multiple
pregnancies greater than twins were reduced to twins at
the 10th gestational week after parents were informed
of the relative risks of high-order multiple pregnancies.
The six clinical pregnancies led to one blighted ovum
and the birth of nine healthy babies, four boys and five
girls, for a live delivery rate (no. of deliveries/no. of
transfer cycles) of 62.5%. All these babies were karyo-
typically and physiologically normal.
Discussion
Almost all patients participating in our study exhibited
an elevated serum FSH level, a low to normal level of
serum testosterone, and atrophic testes, while half of
the patients had mild gynecomastia. The clinical and
hormonal pictures of our patients were similar to those
characteristic of non-mosaic Klinefelter’s syndrome as
reported by a variety of other authors [15,17–24].
Prior to conducting TESE-ICSI, we carefully searched
for the presence of viable sperm in a patient’s ejaculate
using an ESP method on at least three occasions, in
order to use ejaculated sperm as first-line treatment and
thus avoid testicular biopsy for TESE. As a result of the
application of ESP, Ron-El et al [25] and Schlegel [31]
detected viable spermatozoa in 35% and 20% of patients
with non-obstructive azoospermia, respectively. These
spermatozoa could be used for ICSI, avoiding the need
for testicular biopsy in these patients. In Friedler et al’s
study involving 12 patients with non-mosaic Klinefelter’s
syndrome, two patients had totally dead spermatozoa
in their ejaculate, although the authors did not mention
whether spermatozoa were recovered by TESE in these
two patients [23]. Mature spermatozoa were retrieved
from four of nine patients with the azoospermic non-
mosaic 47,XXY karyotype in Tournaye et al’s study [15],
and from four of seven patients in Reubinoff et al’s study
[19]. In both of these studies, three of the four individuals
from whom spermatozoa were recovered had a histo-
ry of spermatozoa in their ejaculates. In our study, one
patient from whom spermatozoa were recovered re-
vealed a history of the presence of spermatozoa in his
ejaculate. Verifying the relative value of using the past
demonstration of spermatozoa in the ejaculate as a
predictor of the success of TESE, however, warrants the
collection of further data from a larger study.
The TESE retrieval rate in our study was 57%. This is
similar to the average TESE success rate of 56% among
non-mosaic Klinefelter’s syndrome patients [23]. It
is also similar to the reported chance of finding
spermatozoa following TESE in the general popula-
tion of patients with non-obstructive azoospermia [32].
A relatively new sperm-retrieval technique, micro-TESE
[30], may be associated with a higher sperm-recovery
rate than other techniques, and may thus become
popular in the future.
In this study, six patients had previously undergone
testicular biopsy for histopathologic examination at
other infertility centers, during which no spermatozoa
had been recovered. Spermatozoa were recovered dur-
ing this current attempt in two of these six individuals,
one of whom had undergone orchiopexy for an unde-
scended testis and simultaneous testicular biopsy dur-
ing a previous attempt. This suggests that neither ear-
lier negative histologic findings nor a lack of sperm
recovery at a previous attempt necessarily precludes
the success of subsequent TESE procedures for azoosper-
mic patients with non-mosaic Klinefelter’s syndrome.
Similar results have been reported in patients suffering
from non-obstructive azoospermia [33,34]. Moreover,
azoospermic individuals suffering from non-mosaic
Klinefelter’s syndrome and an undescended testis are
not necessarily precluded from successful future TESE
for ICSI. In this study, six of eight patients who had not
previously undergone testicular biopsy had successful
recovery of sperm. The difference in success rates between
patients who had or had not undergone previous
testicular biopsy suggests that a previous testicular
biopsy might have compromised the tiny germinal
epithelium in the testis of patients afflicted with non-
mosaic Klinefelter’s syndrome. Determining whether a
previous TESE attempt might elicit a decrease in the
success rate of subsequent attempts requires further
data from a larger study.
Our observation of the range of serum baseline
FSH level, from 13.2 to 83.6 mIU/mL, in patients from
whom spermatozoa were recovered in our study suggests
that a high serum baseline FSH level is not necessarily a
predictor of unsuccessful spermatozoa recovery for
azoospermic patients with non-mosaic Klinefelter’s
syndrome. This point has been raised by other authors
[15,17–24]. Serum inhibin B, a direct product of Sertoli
cells, is a marker of spermatogenesis [35]. In our study,
the serum inhibin B level, determined in four patients,
ranged from less than 15 to 164 pg/mL. Spermatozoa
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were recovered from three of these individuals, who
had serum inhibin B levels of less than 15, 66.1, and
164 pg/mL, respectively. The normal range of serum
inhibin B concentration for a proven father is 94–
327 pg/mL [36]. Although there was a small number
of cases in our study, the results appear to suggest
that serum inhibin B level may not necessarily be an
appropriate predictor of the success of sperm recovery
from azoospermic patients suffering from non-mosaic
Klinefelter’s syndrome. Similar results have been reported
for patients suffering from non-obstructive azoospermia
[36,37].
Our fertilization and embryo-cleavage rates (59%
and 96%, respectively) are similar to those of Friedler et
al, who reported a 66% fertilization rate and a 98%
embryo-cleavage rate [23]. The spermatozoa retrieved
in our study were able to induce similar fertilization and
embryo-cleavage rates as those achieved by spermatozoa
retrieved from patients exhibiting non-obstructive
azoospermia due to other etiology [38]. Our high
implantation rate (24%), high clinical pregnancy rate
(75%), and high live delivery rate (62.5%) may be
attributable to the fairly young age of the women. Silber
et al reported that pathology, source, quantity, or
quality of spermatozoa did not elicit any discernible
effect upon either fertilization or pregnancy rates, and
that the principal factor that dramatically affected
implantation, pregnancy, and delivery rates was maternal
age [38]. Therefore, for cases of male infertility associated
with severe oligospermia or azoospermia, we recommend
that couples seek treatment for their infertility using
ICSI or TESE-ICSI techniques when the female partners
are still young, in order to achieve as high a pregnancy
rate as possible.
Although the couples participating in our study were
informed of the likelihood of achieving high-order multi-
ple pregnancies following ICSI or TESE-ICSI, and were
also informed of the risks associated with continuing
multiple pregnancies subsequent to transferring more
than two embryos to the female partner, several couples
requested that more than three embryos of “the best
quality” be transferred, if available, in order to increase
the chances of achieving a successful pregnancy. Of the
six women achieving clinical pregnancy in our study, five
proved to have multiple pregnancies, including one pair
of twins, two sets of triplets, and two set of quadruplets.
Subsequent to informing the couples of the risk of high-
order multiple pregnancies, all couples with a multiple
pregnancy beyond twins consented to fetal reduction
via a transvaginal approach during the 10th to 12th week
of gestation, to reduce the fetal number to two. All
women who underwent fetal reduction withstood the
operation well and demonstrated a smooth prenatal
course until birth.
A major concern associated with using testicular
spermatozoa derived from patients with Klinefelter’s
syndrome for ICSI is the potential genetic risk to their
offspring. Various studies of chromosomal abnormalities
in ejaculated spermatozoa from patients with mosaic
Klinefelter’s syndrome have revealed an increased rate
of sperm–nuclei abnormalities, the frequency of which
appears to vary from 3.34% to 9.76% [39–43]. The rate
of sperm–nuclei abnormalities in ejaculated spermato-
zoa from patients with non-mosaic Klinefelter’s syn-
drome varies from 3.70% to 21.45% [41,44,45]. While
sex-chromosomal hyperploidy has an incidence of
0.90% to 2.50% for mosaic Klinefelter’s syndrome [39–
43], its incidence in the non-mosaic form appears to
vary from 2.62% to 17.58% [41,44,45]. The rate of
abnormal sperm nuclei and sex-chromosomal hyper-
ploidy in ejaculated sperm among the normal popu-
lation appears to be 0.61–1.32% and 0.37–0.55%,
respectively [40–42,46]. Both successful pregnancies
and births have now been achieved using ICSI with
testicular spermatozoa obtained from azoospermic
patients with non-mosaic Klinefelter’s syndrome. Two
studies report that the aneuploidy rate of retrieved
spermatozoa from the testicular tissues of azoospermic
patients with non-mosaic Klinefelter’s syndrome varies
from 6.30% to 6.75%, and that the rate of corresponding
sex-chromosomal hyperploidy varies from 2.70% to
3.57% [21,22]. Although the rates of both abnormal
sperm nuclei and sex-chromosomal hyperploidy appear
to be elevated for patients afflicted with Klinefelter’s
syndrome compared to the corresponding rates for the
normal population, to the best of our knowledge, at the
time of writing, all babies who were conceived using ICSI
with testicular spermatozoa obtained from azoospermic
patients with non-mosaic Klinefelter’s syndrome have
been both genetically and physiologically normal and
healthy. This includes the 23 children reported in the
literature [17–24] and the nine children in our current
study, but not the one fetus reported by Ron-El et al
[47]. In this study, karyotype analysis from chorionic-
villous sampling during the 10th gestational week in one
woman who achieved a triplet pregnancy using a TESE-
ICSI technique revealed a non-mosaic 47,XXY genotype
for one of the three fetuses. This fetus was reduced dur-
ing the 14th gestational week. Due to the experimental
nature of the TESE-ICSI technique and the relatively
unknown risk of transmission of gonosomal aneuploidy
to embryos obtained by testicular spermatozoa from
patients suffering from Klinefelter’s syndrome, pre-
implantation genetic diagnosis (PGD) by embryo biopsy
may serve as a potent tool to detect chromosomal
aneuploidy in an embryo prior to transfer to the uterus.
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However, not all infertility centers that offer assisted
reproductive technology procedures have the facilities
and skills necessary to undertake PGD. Furthermore,
Munne et al suggest that PGD has several limitations for
aneuploidy detection [48,49], with an error rate of 5.4%
for PGD by fluorescence in situ hybridization (FISH) for
common aneuploidies [49]. This suggests that PGD
cannot yet be considered a reliable technique to detect
chromosomal aneuploidy in an embryo.
Therefore, at present, PGD cannot replace invasive
prenatal diagnostic techniques for fetal karyotyping,
including chorionic-villous sampling or amniocentesis
[19]. In our study, we recommended that couples who
achieve pregnancy undergo amniocentesis for chro-
mosomal karyotyping of their fetuses, although only
one of the five couples with an ongoing pregnancy in our
study agreed to this. The remaining four couples were
willing to take the risk of potential genetic anomalies
in their fetuses and took no action to determine whe-
ther any abnormal sex chromosomal constitution was
apparent in the fetus. For these four couples, we re-
quested frequent monitoring of the developing fetuses
by ultrasound until the babies were born. Subsequent
to birth, all babies from these pregnancies underwent
cytogenetic evaluation using peripheral blood lympho-
cytes; all the babies had normal karyotypes. Our find-
ings suggest that the risk of transmission of gono-
somal aneuploidy using testicular spermatozoa de-
rived from non-mosaic 47,XXY patients is probably
not high, although we do acknowledge a rather small
sample size. Our result is similar to those reported by
others [17–24].
Whether spermatozoa produced by patients suffer-
ing from non-mosaic Klinefelter’s syndrome are the
consequence of meiotic segregation in a 47,XXY germ
cell or a 46,XY germ cell is currently a hotly debated
issue. Some authors have concluded that a 47,XXY
spermatogonium may enter and complete meiosis,
basing their conclusion on indirect evidence, such as
an increase in the 24XY or 24XX spermatozoa rate in
ejaculate potentially derived from 47,XXY spermato-
gonia [39,40,43,44] and a distorted sex ratio of the
spermatozoa examined (excess of 23,X over 23,Y
spermatozoa) [40,45]. On the other hand, other authors
have concluded that only 46,XY spermatogonia are
able to enter and complete meiosis, based on three
observations: only 46,XY pachytene primary sperma-
tocytes have been found in testicular cells obtained
from patients with non-mosaic Klinefelter’s syn-
drome using FISH [21,50]; only 46,XY cells enter and
complete meiosis as revealed by both histology and
microscopy [51,52]; and, most testicular sperm retrieved
from patients with non-mosaic Klinefelter’s syndrome
demonstrate a normal pattern of sex chromosome
segregation [21,22]. Using a murine Klinefelter model,
Hunt et al discovered the demise of all XXY germ cells at
a perinatal age [9], and Morz et al reported that two X-
chromosome reactivations occurred in germ cells during
the early stage of XXY mouse testis differentiation [53].
This altered X chromosome dosage in XXY germ cells
acts to impair their continued survival [53]. Morz et al
also found that exceptional germ cells which survive in
the postnatal XXY testis are exclusively XY and result
from rare mitotic non-disjunction events that give rise to
clones of XY cells, and concluded that all spermatozoa
found in an XXY mouse testis were exclusively yielded
by XY germ cells [53]. Authors who previously advocated
that only XY spermatogonia could enter and complete
meiosis thought that a slight increase in chromosomal
abnormalities and, in particular, the sex chromosome
aneuploidy rate in spermatozoa found in patients with
Klinefelter’s syndrome were most probably related to
meiotic errors of normal XY spermatogonia in a com-
promised testicular environment rather than to abnor-
mal spermatogenic cell lines [21,22,50]. Morz et al sub-
stantiated this hypothesis using a murine Klinefelter
model [54]. Consistent with this view, several studies
have also reported a slight increase in chromosomal
abnormalities, in particular, the rate of sex chromosome
aneuploidies, for other types of infertile and subfertile
males [55–57]. We determined the sex ratio among
deliveries of all pregnancies achieved following TESE-
ICSI for azoospermic patients suffering from non-mosaic
Klinefelter’s syndrome in reported studies [17–24] and
our current study, and found no excess of girls over boys
for either literature-based studies or our own study.
Furthermore, all babies proved to be chromosomally
normal, apart from a single XXY fetus [47]. This evidence
may indirectly support the notion that spermatozoa
retrieved from patients with non-mosaic Klinefelter’s
syndrome are produced by XY germ cells rather than XXY
germ cells. Thus, the risk of using sperm from a non-
mosaic 47,XXY patient would appear to be lower than
expected; the offspring produced would not yield any
resultant excess of females over males.
In conclusion, our results suggest that spermatozoa
can be retrieved from azoospermic patients with non-
mosaic Klinefelter’s syndrome using a TESE technique.
Furthermore, it may be possible to use the spermatozoa
to induce normal fertilization by ICSI, normal embryo
cleavage, and the birth of a karyotypically and physio-
logically normal baby. Our results should encourage
and reassure physicians and their patients with non-
mosaic Klinefelter’s syndrome who are pursuing the
use of patients’ own sperm in treatment for infertility.
Based on the literature and our results, it appears that
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babies resulting from the application of an ICSI tech-
nique using testicular spermatozoa obtained from
azoospermic patients with non-mosaic Klinefelter’s syn-
drome are likely to be normal and healthy. We acknow-
ledge that only limited data have yet been obtained per-
taining to the potential risk of transmission of gonoso-
mal aneuploidies to babies produced using testicular
spermatozoa from azoospermic patients with non-
mosaic Klinefelter’s syndrome, and suggest that it is
necessary to undertake detailed counseling of such
patients regarding the potential genetic risks facing
the offspring produced using the patients’ own sperm.
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